Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2025-12-24 @ 2:06 PM
NCT ID:
NCT02182895
Eligibility Criteria:
Inclusion Criteria:
* Patients with T2DM and HbA1C ≤7.5% on ≤1 non-insulin hypoglycemic agent or HbA1C ≤7.0% on ≤2 non-insulin hypoglycemic agents admitted to the hospital for a non-critical illness.
* Written informed consent.
Exclusion Criteria:
* Admitted to or expected to require admission to ICU
* Patients with a history of diabetic ketoacidosis or hyperosmolar state
* HbA1c \>7.5% at the time of admission or within 3 months before admission
* Insulin requiring before admission
* Unable to take oral food or medications
* Systemic steroid use
* Pregnancy or breastfeeding
* Women of Child-Bearing Potential (WOCBP) who are unwilling or unable to use an acceptable method to avoid pregnancy for the entire study period and up to 4 weeks after the last dose of study drug.
* History of pancreatitis or active gallbladder disease
* End stage renal disease on dialysis
* Hypersensitivity to saxagliptin or another contraindication to DPP4 inhibitors
* Subject unable to give informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
110 Years
Study:
NCT02182895
Study Brief:
Protocol Section:
NCT02182895